EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Molecular Characterization of Mobilized Apheresis Hematopoietic Progenitor Cells Designated for Autologous Stem Cell Transplantation in Multiple Myeloma

Gurmukh Singh, Kiana Kim, Roni J Bollag

eJHaem · 2026-10 · 7 (5)

DOI: 10.1002/jha2.70408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eJHaem, online erschienen am 28.09.2026. Verfasst von Gurmukh Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology Medical College of Georgia Augusta University Augusta Georgia USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Multiple myeloma is the second most common malignancy of the lymphoid system and accounts for about 2% of cancer deaths. Treatment generally consists of chemotherapy and autologous stem cell transplantation. Clinical trial results are equivocal as to whether autologous stem cell transplantation in the treatment of multiple myeloma prolongs overall survival. One possible etiology for this conundrum could be that the transplanted autologous stem cells may also contain residual tumor cells/tumor stem cells.

Methods

Residual autologous stem cells from patients undergoing stem cell transplantation were examined for cells containing monoclonal immunoglobulins and clonotypic DNA detected in diagnostic bone marrow to determine if malignant myeloma cells may have been transplanted along with hematopoietic stem cells.

Results

In all eight cases of autologous stem cell transplants examined from multiple myeloma patients, the infused cells included cells containing monoclonal immunoglobulins of the same type as were noted in patients' sera at the time of diagnosis. This was not seen in allogeneic cells from donors without cancer. In all four cases in which a dominant clone was identified by molecular analysis in the diagnostic bone marrow, the same clone was detectable in the autologous stem cells.

Conclusions

We posit that lack of prolongation of overall survival with autologous stem cell transplantation in multiple myeloma is in part due to infusion of cells containing tumor cells that repopulate the recipient. This finding may warrant novel collection and processing strategies to mitigate the infusion of malignant cells. Until such methods become available, the use of autologous stem cell transplantation should be considered in the context of the conundrum reported here. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission

Schlagwörter

Stichwörter der Autor:innen

autologous stem cell transplantationclonal markersmonoclonal immunoglobulinsmultiple myelomaoverall survivalprogression‐free survival

Autor:innen und Institutionen

  • Department of Pathology Medical College of Georgia Augusta University Augusta Georgia USA.

Zitieren

APA

Singh, G., Kim, K., & Bollag, R. J. (2026). Molecular Characterization of Mobilized Apheresis Hematopoietic Progenitor Cells Designated for Autologous Stem Cell Transplantation in Multiple Myeloma. eJHaem, 7(5). https://doi.org/10.1002/jha2.70408

Vancouver

Singh G, Kim K, Bollag RJ. Molecular Characterization of Mobilized Apheresis Hematopoietic Progenitor Cells Designated for Autologous Stem Cell Transplantation in Multiple Myeloma. eJHaem. 2026;7(5). doi:10.1002/jha2.70408

BibTeX
@article{Singh2026,
  author = {Singh, Gurmukh and Kim, Kiana and Bollag, Roni J},
  title = {Molecular Characterization of Mobilized Apheresis Hematopoietic Progenitor Cells Designated for Autologous Stem Cell Transplantation in Multiple Myeloma},
  journal = {eJHaem},
  year = {2026},
  volume = {7},
  number = {5},
  doi = {10.1002/jha2.70408}
}
Kostenlos starten →